Technical Analysis for MNK - Mallinckrodt plc

Grade Last Price % Change Price Change
grade F 2.44 0.00% 0.00
MNK closed unchanged on Friday, September 20, 2019, on 2.7 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical MNK trend table...

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Spinning Top Other 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Calm After Storm Range Contraction -3.56%
Narrow Range Bar Range Contraction -3.56%
NR7 Range Contraction -3.56%

Older signals for MNK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide. The company's Specialty Pharmaceuticals segment offers EXALGO extended-release tablets to treat pain in opioid-tolerant patients; and GABLOFEN injections indicated for use in the management of spasticity of cerebral or spinal origin in patients age four years and above. This segment also provides generic drugs, such as oxycodone or in combination with acetaminophen, as well as hydrocodone, which in combination with acetaminophen to treat pain; and methylphenidate to treat attention deficit hyperactivity disorder. This segment markets its branded products to physicians, including pain specialists, anesthesiologists, orthopedic surgeons, rheumatologists, and neurologists; and generic products to wholesalers, large- and medium-sized retail pharmacy chains, food store chains with pharmacies, mail order pharmacies, and other channels of distribution. Its Global Medical Imaging segment provides contrast media and delivery systems comprising iodine- and gadolinium-containing injectable products for diagnostic imaging applications, such as computed tomography and magnetic resonance imaging under the Optiray and Optimark brand names. This segment also offers nuclear imaging agents consisting of Technescan MAG3, a nuclear imaging agent to detect and evaluate a range of renal disorders; technetium-99m for use in Ultra-Technekow DTE generators; cold kits; and other radiopharmaceuticals, such as Octreoscan to detect cancer. This segment sells its contrast media systems to hospitals and hospital groups; branded products directly to managed care organizations; and API products to other pharmaceutical companies. The company was incorporated in 2013 and is based in Dublin, Ireland. Mallinckrodt plc (NYSE:MNK) operates independently of Covidien plc as of June 28, 2013.
Medicine Cancer Physical Sciences Pharmaceutical Pain Natural Sciences Pharmaceutical Industry In China Medical Imaging Active Pharmaceutical Ingredients Diagnostic Imaging Medical Physics Magnetic Resonance Imaging Tomography Attention Deficit Hyperactivity Disorder Medicinal Radiochemistry Radiopharmaceuticals Contrast Media Covidien Generic Products Radiochemistry Renal Disorders
Is MNK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 32.34
52 Week Low 1.43
Average Volume 9,134,316
200-Day Moving Average 14.2984
50-Day Moving Average 4.8528
20-Day Moving Average 2.9205
10-Day Moving Average 2.856
Average True Range 0.5503
ADX 27.79
+DI 28.3357
-DI 30.9754
Chandelier Exit (Long, 3 ATRs ) 3.0791
Chandelier Exit (Short, 3 ATRs ) 3.0809
Upper Bollinger Band 4.3194
Lower Bollinger Band 1.5216
Percent B (%b) 0.33
BandWidth 95.798665
MACD Line -0.6458
MACD Signal Line -0.7532
MACD Histogram 0.1074
Fundamentals Value
Market Cap 236.77 Million
Num Shares 97 Million
EPS -4.63
Price-to-Earnings (P/E) Ratio -0.53
Price-to-Sales 0.92
Price-to-Book 0.59
PEG Ratio 0.79
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.17
Resistance 3 (R3) 3.21 3.00 3.05
Resistance 2 (R2) 3.00 2.82 2.98 3.01
Resistance 1 (R1) 2.72 2.70 2.86 2.68 2.97
Pivot Point 2.52 2.52 2.59 2.50 2.52
Support 1 (S1) 2.23 2.33 2.38 2.20 1.91
Support 2 (S2) 2.03 2.21 2.01 1.87
Support 3 (S3) 1.75 2.03 1.83
Support 4 (S4) 1.71